Professor John Rasko, Head of the Gene and Stem Cell Therapy Program at the Centenary Institute has been profiled in a NSW Health & Medical Research article.
He’s trying to find cures for the world’s most common blood disorders.
“We can imagine a future where we can remove disease-causing genes and let people enjoy a healthy life. But that brings up questions of how we see health and disease, and where we draw the line between treatment and disease eradication, versus enhancement,” says Professor Rasko.”
Click here to read more about Professor Rasko’s exciting work and the complex ethical and legal issues that are intrinsic to gene therapy activity.
Professor John Rasko AO has led a world-first clinical trial into engineered stem cell treatment use, treating 15 patients with steroid resistant acute graft-versus-host disease.
Centenary Institute research has discovered that the lack of an enzyme in the liver called sphingosine kinase 2 results in pronounced insulin resistance and glucose intolerance, both symptoms of early stage type 2 diabetes.
Research led by the Centenary Institute has shown that a healthy weight and coffee consumption may help lower the risk of high-risk drinkers developing alcohol-induced cirrhosis.